Filing Details
- Accession Number:
- 0001593968-21-001293
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-12 13:00:00
- Reporting Period:
- 2021-05-10
- Accepted Time:
- 2021-05-12 17:29:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1771917 | Karuna Therapeutics Inc. | KRTX | Pharmaceutical Preparations (2834) | 270605902 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1777760 | Craig Andrew Miller | C/O Karuna Therapeutics, Inc. 99 High Street, 26Th Floor Boston MA 02110 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-10 | 5,000 | $9.20 | 50,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-10 | 5,000 | $110.43 | 45,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2021-05-10 | 5,000 | $0.00 | 5,000 | $9.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
300,492 | 2019-04-21 | 2029-03-21 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.